CCRN — Cross Country Healthcare Income Statement
0.000.00%
Last trade - 00:00- $296.69m
- $187.95m
- $1.05bn
Annual income statement for Cross Country Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,677 | 2,807 | 2,020 | 1,344 | 1,054 |
| Cost of Revenue | |||||
| Gross Profit | 375 | 628 | 450 | 274 | 214 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,537 | 2,537 | 1,909 | 1,361 | 1,139 |
| Operating Profit | 139 | 269 | 111 | -16.9 | -84.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 133 | 256 | 103 | -16.4 | -83.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 132 | 188 | 72.6 | -14.6 | -94.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 132 | 188 | 72.6 | -14.6 | -94.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 132 | 188 | 72.6 | -14.6 | -94.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.68 | 5.25 | 2.17 | -0.083 | -1.18 |